Lab Members
Jianjun Zhang, M.D., Ph.D.
Professor
JZhang20@MDAnderson.org
Department of Thoracic/Head and Neck Medical Oncology
Department of Genomic Medicine
Director of Lung Cancer Interception Program
2002 Chinese Academy of Medical Sciences and Peking Union Medical College, Ph.D.
1997 Tongji Medical University, M.D.
Hong Chen, Ph.D.
Research Scientist
HChen14@MDAnderson.org
2018 Harbin Medical University, Ph.D.
Hong’s research primarily focuses on a comprehensive single-cell transcriptomic analysis that examines the malignant transformation of normal lung tissue to lung adenocarcinoma (LUAD) in mouse models. She is investigating the oncogenic initiation and progression of tumor cells, as well as the dynamic interactions between tumor cells and the tumor microenvironment (TME) over time.
Xin (Kathy) Hu, Ph.D.
Data Scientist
XHu3@MDAnderson.org
2017 MD Anderson UTHealth Houston Graduate School, Ph.D.
As a data scientist, Kathy has been working in the field of bioinformatics, computational biology, cancer genomics and immuno-oncology by analyzing methylome, genome, single cell sequencing profiling, to explore tumor cell heterogeneity, precancerous evolution, and immune microenvironment interactions in LUAD, with contribution to multiple publications and projects that advance the understanding and treatment of cancer and other diseases to improve human health.
Chenyang (Skylar) Li, B.S.
PhD Student
CLi15@MDAnderson.org
2019 University of Science and Technology of China, B.S.
Skylar focuses on computational immuno-oncology, developing computational methods to study the tumor microenvironment from multi-modality data and constructing models or identifying biomarkers for patient risk evaluation or drug response prediction.
Hui Li, M.D., Ph.D.
Research Scientist
HLi27@MDAnderson.org
2010 Clinical Medicine, Shanxi Medical University, M.D.
2015 Oncology, Peking University, Ph.D.
Hui is a research scientist in the Department of Imaging Physics and Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center. Her research focuses on advancing early detection strategies for lung cancer by evaluating the malignancy risk of pulmonary nodules to enable timely diagnosis and intervention. She also investigates various factors, including biomarkers, that may predict treatment effectiveness and patient prognosis. Her work is dedicated to identifying patients who will benefit most from different therapies such as chemotherapy, targeted therapy, and immunotherapy, with a focus on optimizing personalized treatment approaches to ultimately improving patient outcomes.
Kang (Cecilia) Qin, M.D.
Postdoctoral Fellow
KQin@MDAnderson.org
2020 Qingdao University, M.D.
Cecilia’s research projects focus on lung cancer treatment, precancer development, immunotherapy, targeted therapy for non-small cell lung cancer, genomics, cancer immunology, intra-tumor heterogeneity and the tumor microenvironment (TME).
Yanhua Tian, Ph.D.
Instructor
YTian2@MDAnderson.org
2019 Peking University, Ph.D.
Utilizing cutting-edge technologies, including single cell sequencing and advanced spatial gene and protein analyses, Yanhua is committed to an in-depth exploration of the tumor microenvironment (TME) throughout tumor initiation, invasion, and metastasis. By conducting molecular profiling of diverse cellular populations, immune landscapes, and key molecules within the TME, his goal is to unravel the complex dynamics driving tumor progression mechanisms.
Jie Ye, BMed.
Ph.D. Student
JYe1@MDAnderson.org
Jie is investigating intratumor heterogeneity in lung cancer through multi-omics sequencing approaches. Her research focuses on deconvoluting the subclonal architecture of tumor cells to gain insights into the mechanisms driving tumor development and progression.
Bo Zhu, Ph.D.
Instructor
BZhu1@MDAnderson.org
2017 Fudan University, Ph.D.
Bo’s research focuses on early-stage lung cancer, utilizing single-cell RNA sequencing, Imaging Mass Cytometry, and spatial transcriptomics (including Visium HD, and Xenium) to profile specimens from human and mouse models. His goal is to uncover cancer initiation mechanisms and identify new targets for lung cancer prevention.